Novanta Reports Q1 Revenue Growth, EPS Decline Amid Restructuring and New Geopolitical Risks

summarizeSummary

Novanta Inc. reported a 10.4% increase in Q1 revenue to $257.7 million, but diluted EPS decreased to $0.51 due to higher operating expenses and increased weighted average shares outstanding. The company is continuing its restructuring programs and highlighted new geopolitical risks.

check_boxKey Events

• Q1 Revenue Up 10.4%

  Novanta reported first-quarter revenue of $257.7 million, a 10.4% increase year-over-year, driven by growth in both Automation Enabling Technologies and Medical Solutions segments.

• Diluted EPS Decreased

  Diluted earnings per share fell to $0.51 from $0.59 in the prior year, primarily due to increased weighted average common shares outstanding from a prior tangible equity unit offering and higher operating expenses.

• Increased Restructuring Costs Impact Profitability

  Restructuring, acquisition, and related costs increased to $2.6 million in Q1 2026, compared to a gain in the prior year, contributing to a 15.1% decline in operating income. The company expects total 2025 restructuring charges to be approximately $25 million.

• Active Share Repurchase Program

  Novanta repurchased $18.6 million in common shares during the quarter, completing its 2020 plan and continuing under the $200 million 2025 repurchase plan with $191.6 million remaining.

auto_awesomeAnalysis

Novanta's first-quarter results show solid revenue growth, but profitability was impacted by higher operating expenses and ongoing restructuring initiatives. The decline in diluted EPS, despite revenue gains, is a key concern for investors. The company's continued share repurchases indicate a commitment to returning capital, but the newly disclosed geopolitical risk factor adds a layer of uncertainty regarding future operational stability and costs.